Five Things For Pharmacists To Know About The Treatment Of Mycobacterium Tuberculosis
IDStewardship
JUNE 19, 2025
Despite advancements in treatment, certain patients may exhibit delayed responses, have drug-resistant TB, be at risk for drug-drug interactions, or have comorbid conditions that considerably complicate clinical management. Gillespie, Martin J. Boeree, Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?, 923-32) 5.
130 
Let's personalize your content